The novel complexes [(bpy) 2 (PnR3) RuIV (0)](C104) 2 (where bpy= 2, 2'-bipyridine and
PnR3= tertiary phosphine or arsine) have been generated from the analogous ruthenium (II)-…

A folate-receptor-targeted 99m Tc-radiopharmaceutical, [ 99m Tc]Tc(CO) 3 DTPA-folate, was
prepared by heating [ 99m Tc]Tc(CO) 3 (H 2 O) 3 + in an aqueous solution of the previously …

(2.2% Injecteddoseat 1 hr postinjectionunderrestingcondi tions) and no detectable myocard@
washout or redistributionup to 5 hr posbnjec@ on. The t@ OdiStdbUtIOnis characte&ed …

Overexpression of the multidrug resistance (MDR1) P-glycoprotein (Pgp) correlates with
cancer chemotherapeutic failure. Lipophilic cationic radiopharmaceuticals such as 99mTc-…

• C-reactive protein (CRP) concentrations were monitored serially in 97 patients with abdominal
sepsis to determine if differences in infection type or site would produce diagnostic or …

The chemistry of high-valent ruthenium-oxo complexes has received muchattention recently
due to the potential applications of these complexes as oxidation catalystsand as oxygen …

A series of 23 technetium(III) complexes of the type [TcL(PR 3 ) 2 ]+, where L represents a
tetradentate Schiff base ligand in the equatorial plane and PR 3 represents the axial …

Various tetradentate N 3 S ligands which contain pyridyl, morpholino, or imidazolyl moieties
were prepared and labeled with technetium and rhenium. Metal complexation of the ligands …

Kinetic and mechanistic studies on the oxidation of a series of alcohols by [RuIVO(bipy)2(ER3)]2+(bipy
= 2,2′-bipyridine and ER3 is a tertiary phosphine or arsine ligand) have been …

Introduction There has been much current interest in the synthesis and reactivity of oxoruthenium
(IV) and dioxoruthenium (VI) com-plexes, with a focus on the role of the ligands in the …